Form 4 for XFOR X4 Pharmaceuticals, Inc
Accepted 2025-10-27 00:00:00 ET · period of report 2025-10-23 · accession 0001501697-25-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-27 | 2025-10-23 | XFOR | Craig Adam R | Executive COB, Dir | P - Purchase | $2.90 | +86.2K | 376.1K | +30% | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-23 | P | A | 86,206 | $2.90 | 376,087 | D | — | — | (F1) Consists of shares of the Issuer's common stock purchased in connection with the Issuer's public offering. |